DG vs JAZZ · P/E 15, rev $22.08B vs P/E 1988, rev $2.28B
Dollar General Corporation (DG) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Dollar General Corporation (DG) is a discount stores company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported DG revenue for 2026-07-31 was $22.08B. Net income was $994.4M. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
DG currently screens at market cap $22.87B and trailing P/E 14.7. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the DG and JAZZ stock pages for the full models.
Not investment advice.